机构:[1]Department of Thoracic Surgery, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Ji'nan, Shandong, China.[2]Department of Interventional Radiology, Shandong Cancer Hospital and Institute Affiliated Shandong First Medical University and Shandong Academy of Medical Sciences, Ji'nan, Shandong, China.[3]Key Laboratory of Transplant Engineering and Immunology, NHC, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, China.四川大学华西医院
第一作者机构:[1]Department of Thoracic Surgery, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Ji'nan, Shandong, China.
通讯作者:
通讯机构:[2]Department of Interventional Radiology, Shandong Cancer Hospital and Institute Affiliated Shandong First Medical University and Shandong Academy of Medical Sciences, Ji'nan, Shandong, China.[*1]Department of Interventional Radiology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, No. 440, Jiyan Road, Ji’nan, Shandong Province, CN, 250117, China
推荐引用方式(GB/T 7714):
Zhang Jing-Shun,Sun Yuan-Dong,Li Yuan-Min,et al.Application of combined ablation and immunotherapy in NSCLC and liver cancer: Current status and future prospects[J].Heliyon.2024,10(16):e36388.doi:10.1016/j.heliyon.2024.e36388.
APA:
Zhang Jing-Shun,Sun Yuan-Dong,Li Yuan-Min&Han Jian-Jun.(2024).Application of combined ablation and immunotherapy in NSCLC and liver cancer: Current status and future prospects.Heliyon,10,(16)
MLA:
Zhang Jing-Shun,et al."Application of combined ablation and immunotherapy in NSCLC and liver cancer: Current status and future prospects".Heliyon 10..16(2024):e36388